Synaffix Aims For Top ADC Tech Provider Spot After Inking MacroGenics Deal

Pact Potentially Worth $586m

Arrow hitting bullseye representing success.
Synaffix Hopes To Become Top Dog In Antibody Drug Conjugate Technology • Source: Alamy

More from Deals

More from Business